Cargando…
A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor
[Image: see text] The yeast Saccharomyces cerevisiae is commonly used to interrogate and screen protein variants and to perform directed evolution studies to develop proteins with enhanced features. While several techniques have been described that help enable the use of yeast for directed evolution...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661033/ https://www.ncbi.nlm.nih.gov/pubmed/37873982 http://dx.doi.org/10.1021/acssynbio.3c00299 |
_version_ | 1785148449137623040 |
---|---|
author | Cazier, Andrew P. Irvin, Olivia M. Chávez, Lizmarie S. Dalvi, Saachi Abraham, Hannah Wickramanayake, Nevinka Yellayi, Sreenivas Blazeck, John |
author_facet | Cazier, Andrew P. Irvin, Olivia M. Chávez, Lizmarie S. Dalvi, Saachi Abraham, Hannah Wickramanayake, Nevinka Yellayi, Sreenivas Blazeck, John |
author_sort | Cazier, Andrew P. |
collection | PubMed |
description | [Image: see text] The yeast Saccharomyces cerevisiae is commonly used to interrogate and screen protein variants and to perform directed evolution studies to develop proteins with enhanced features. While several techniques have been described that help enable the use of yeast for directed evolution, there remains a need to increase their speed and ease of use. Here we present yDBE, a yeast diversifying base editor that functions in vivo and employs a CRISPR-dCas9-directed cytidine deaminase base editor to diversify DNA in a targeted, rapid, and high-breadth manner. To develop yDBE, we enhanced the mutation rate of an initial base editor by employing improved deaminase variants and characterizing several scaffolded guide constructs. We then demonstrate the ability of the yDBE platform to improve the affinity of a displayed antibody scFv, rapidly generating diversified libraries and isolating improved binders via cell sorting. By performing high-throughput sequencing analysis of the high-activity yDBE, we show that it enables a mutation rate of 2.13 × 10(–4) substitutions/bp/generation over a window of 100 bp. As yDBE functions entirely in vivo and can be easily programmed to diversify nearly any such window of DNA, we posit that it can be a powerful tool for facilitating a variety of directed evolution experiments. |
format | Online Article Text |
id | pubmed-10661033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-106610332023-11-21 A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor Cazier, Andrew P. Irvin, Olivia M. Chávez, Lizmarie S. Dalvi, Saachi Abraham, Hannah Wickramanayake, Nevinka Yellayi, Sreenivas Blazeck, John ACS Synth Biol [Image: see text] The yeast Saccharomyces cerevisiae is commonly used to interrogate and screen protein variants and to perform directed evolution studies to develop proteins with enhanced features. While several techniques have been described that help enable the use of yeast for directed evolution, there remains a need to increase their speed and ease of use. Here we present yDBE, a yeast diversifying base editor that functions in vivo and employs a CRISPR-dCas9-directed cytidine deaminase base editor to diversify DNA in a targeted, rapid, and high-breadth manner. To develop yDBE, we enhanced the mutation rate of an initial base editor by employing improved deaminase variants and characterizing several scaffolded guide constructs. We then demonstrate the ability of the yDBE platform to improve the affinity of a displayed antibody scFv, rapidly generating diversified libraries and isolating improved binders via cell sorting. By performing high-throughput sequencing analysis of the high-activity yDBE, we show that it enables a mutation rate of 2.13 × 10(–4) substitutions/bp/generation over a window of 100 bp. As yDBE functions entirely in vivo and can be easily programmed to diversify nearly any such window of DNA, we posit that it can be a powerful tool for facilitating a variety of directed evolution experiments. American Chemical Society 2023-10-24 /pmc/articles/PMC10661033/ /pubmed/37873982 http://dx.doi.org/10.1021/acssynbio.3c00299 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Cazier, Andrew P. Irvin, Olivia M. Chávez, Lizmarie S. Dalvi, Saachi Abraham, Hannah Wickramanayake, Nevinka Yellayi, Sreenivas Blazeck, John A Rapid Antibody Enhancement Platform in Saccharomyces cerevisiae Using an Improved, Diversifying CRISPR Base Editor |
title | A Rapid Antibody
Enhancement Platform in Saccharomyces
cerevisiae Using an Improved, Diversifying CRISPR Base Editor |
title_full | A Rapid Antibody
Enhancement Platform in Saccharomyces
cerevisiae Using an Improved, Diversifying CRISPR Base Editor |
title_fullStr | A Rapid Antibody
Enhancement Platform in Saccharomyces
cerevisiae Using an Improved, Diversifying CRISPR Base Editor |
title_full_unstemmed | A Rapid Antibody
Enhancement Platform in Saccharomyces
cerevisiae Using an Improved, Diversifying CRISPR Base Editor |
title_short | A Rapid Antibody
Enhancement Platform in Saccharomyces
cerevisiae Using an Improved, Diversifying CRISPR Base Editor |
title_sort | rapid antibody
enhancement platform in saccharomyces
cerevisiae using an improved, diversifying crispr base editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661033/ https://www.ncbi.nlm.nih.gov/pubmed/37873982 http://dx.doi.org/10.1021/acssynbio.3c00299 |
work_keys_str_mv | AT cazierandrewp arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT irvinoliviam arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT chavezlizmaries arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT dalvisaachi arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT abrahamhannah arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT wickramanayakenevinka arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT yellayisreenivas arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT blazeckjohn arapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT cazierandrewp rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT irvinoliviam rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT chavezlizmaries rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT dalvisaachi rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT abrahamhannah rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT wickramanayakenevinka rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT yellayisreenivas rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor AT blazeckjohn rapidantibodyenhancementplatforminsaccharomycescerevisiaeusinganimproveddiversifyingcrisprbaseeditor |